J1072 HCPCS Level II code: Injection, testosterone cypionate (azmiro), 1 mg

J1072 is the HCPCS code for “Injection, testosterone cypionate (azmiro), 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J1072

Injection, testosterone cypionate (azmiro), 1 mg

Short description: Inj, testosterone, azmiro

HCPCS · United States

Notes for J1072

As CMS prints them, with any note J1072 takes from the headings above it.

Note

  • CMS processing note 0194: PUB. 100-4, CH. 15.

Medicare details

The indicators CMS publishes with J1072 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Other drugs
Added
Apr 1, 2025

Where J1072 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J1072Injection, testosterone cypionate (azmiro), 1 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J1072 mean?

J1072 is the HCPCS code for “Injection, testosterone cypionate (azmiro), 1 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J1072?

CMS lists J1072’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.